Taiwan FDA registration be580e4150f6d20222388f0aaf1ec96d
Londo-Direct bilirubin reagent
TW: 倫多-直接膽紅素試劑
Taiwan·Risk Class 2·RANDOX LABORATORIES LTD·Registered Mar 22, 2006 – Mar 22, 2011CancelledRegistration details
- Analysis ID
- be580e4150f6d20222388f0aaf1ec96d
- Customs Code
- DHA00601619307
Company information
- Manufacturer
- RANDOX LABORATORIES LTD
- Manufacturer Country
- United Kingdom
- Authorized Representative
- EUGENE-CHEN CO., LTD.
Product details
- Intended Use
- Quantify the total amount of red in serum and blood.
- Product Type (Level 1)
- A Clinical chemistry and clinical toxicology
- Product Type (Level 2)
- A.1110 Bilirubin (total or direct) test system
- Import Information
- import
Dates and status
- Registration Date
- Mar 22, 2006
- Expiry Date
- Mar 22, 2011
- Cancellation Date
- Oct 13, 2011
Cancellation information
- Status
- Logged out
- Reason
- 許可證已逾有效期
About this record
Access comprehensive regulatory information for Londo-Direct bilirubin reagent in Taiwan's medical device market through Pure Global AI's free database. This Risk Class 2 medical device is registered under number be580e4150f6d20222388f0aaf1ec96d and manufactured by RANDOX LABORATORIES LTD. The authorized representative in Taiwan is EUGENE-CHEN CO., LTD..
This page provides complete technical specifications, regulatory compliance details. Pure Global AI offers free access to 89,000+ Taiwan medical device registrations, helping global MedTech companies navigate Taiwan FDA regulations, identify competitors, and discover partnership opportunities efficiently.
Free DatabasePowered by Pure Global AI89,000+ Devices